Making best practice, everyday practice

Login Register

Accredited CPD Modules

Earn up to 3 CPD points per module

deNovo Medica provides an expert platform for continuing medical education in South Africa, earning the HPCSA health care professionals valuable accredited CPD points.

Register for our Accredited Education Modules to earn your CPD points.

For more information visit our FREQUENTLY ASKED QUESTIONS.

What’s new in atrial fibrillation?Ultrathin StrutBioresorbable-polymer stent sets new standard in drug-eluting stent technologyAmerican College of Cardiology Congress update 2020Case studies: Management of anginaManaging anticoagulation in cancer-associated thrombosisDapagliflozin improves outcomes in heart failure patientsManaging anticoagulation in eligible non-valvular atrial fibrillation (AF)ESC Congress 2019 – clinical update from SA expertsProviding essential diagnostic data in high-risk cardiac patientsGuideline-based approaches to reducing cardiovascular risk in diabetesLooking ahead – The International Diabetes and Cardiovascular Summit, MoscowBioresorbable polymer stents for high-risk coronary artery disease patientsAmerican College of Cardiology 2019 Scientific SessionsCOVID-19 and Cardiovascular DiseaseClinical Issues – Cardiovascular disease in heart failure and rheumatoid diseaseStatins in older patients
Diabetes and thromboembolic riskDiabetes and Ramadan practical guidelinesGLP-1 Summit – Key learnings about the added benefits of GLP-1 in diabetesWhy do SGLT-2 inhibitors reduce the risk of heart failure events?Cross-talk between the kidneys and circulation in diabetesHow to use insulin glargine U300 in everyday clinical practice?Long-acting insulin glargine-300Does it matter how you lower glucose?Diabetes and heart failureLatest clinical guidelines for type 2 diabetes – Interpreting the 2018 ADA/EASD GuidelinesThe kidney – the heart of the matter in diabetesEarly intensive glucose control – what can we do better in type 2 diabetes management?What physicians need to know about SGLT-2 inhibitorsSGLT-2 inhibitors in type 2 diabetes – protecting the kidney (and heart) beyond glucose control